Anthony T Reder

7PUBLICATIONS
8CO-AUTHORS
Vision scienceNeurology and neuromuscular diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical molecular engineering of nucleic acids and proteinsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 30, 2026
Two Years of Ocrelizumab Treatment in Black and Hispanic People with Multiple Sclerosis in CHIMES: A Single-Arm Clinical Trial.

|Jun 10, 2026
Long-Term IFN-β Therapy Enhances and Prolongs IFN Responses in Multiple Sclerosis.

|Sep 19, 2025
IFN-β therapy rescues dysregulated IFN-stimulated proteins, serum cytokines, and neurotrophic factors in multiple sclerosis: Multiplex analysis of short-term and long-term IFN responses.

Lei Li, Maya Olcer, Zhe Wang

|Mar 03, 2023
Prolonged Interferon-Stimulated Gene and Protein Signatures in Multiple Sclerosis Induced by PEGylated IFN-β-1a Compared to Non-PEGylated IFN-β-1a.

Kristi Nguyen, Maya Olcer, Quentin Howlett-Prieto

|Mar 20, 2021
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies.

Anthony T Reder, Diego Centonze, Maria L Naylor

|Oct 07, 2020
Asymptomatic brainstem lesions and pachymeningeal enhancement after anti-PD-1 therapy.

Carlen A Yuen, Kourosh Rezania, Deric M Park

Pageof 2

Frequent Collaborators

1 joint publications

Diego Centonze

1 joint publications

Anjali Nagpal

1 joint publications

Maya Olcer

1 joint publications

Yaerin Song